Abstract:Terminal differentiation of B cells depends on two interconnected survival pathways, elicited by the B-cell receptor (BCR) and the BAFF receptor (BAFF-R), respectively. Loss of either signaling pathway arrests B-cell development. Although BCR-dependent survival depends mainly on the activation of the v-AKT murine thymoma viral oncogene homolog 1 (AKT)/PI3-kinase network, BAFF/BAFF-R-mediated survival engages non-canonical NF-κB signaling as well as MAPK/extracellular-signal regulated kinase and AKT/PI3-kinase modules to allow proper B-cell development. Plasma cell survival, however, is independent of BAFF-R and regulated by APRIL that signals NF-κB activation via alternative receptors, that is, transmembrane activator and CAML interactor (TACI) or B-cell maturation (BCMA). All these complex signaling events are believed to secure survival by increased expression of anti-apoptotic B-cell lymphoma 2 (Bcl2) family proteins in developing and mature B cells. Curiously, how lack of BAFF- or APRIL-mediated signaling triggers B-cell apoptosis remains largely unexplored. Here, we show that two pro-apoptotic members of the ‘Bcl2 homology domain 3-only’ subgroup of the Bcl2 family, Bcl2 interacting mediator of cell death (Bim) and Bcl2 modifying factor (Bmf), mediate apoptosis in the context of TACI-Ig overexpression that effectively neutralizes BAFF as well as APRIL. Surprisingly, although Bcl2 overexpression triggers B-cell hyperplasia exceeding the one observed in Bim−/−Bmf−/− mice, Bcl2 transgenic B cells remain susceptible to the effects of TACI-Ig expression in vivo, leading to ameliorated pathology in Vav-Bcl2 transgenic mice. Together, our findings shed new light on the molecular machinery restricting B-cell survival during development, normal homeostasis and under pathological conditions. Our data further suggest that Bcl2 antagonists might improve the potency of BAFF/APRIL-depletion strategies in B-cell-driven pathologies.

Interferon-beta mediates stromal cell rescue of T cells from apoptosis

Splenic Stroma-Educated Regulatory Dendritic Cells Induce Apoptosis of Activated CD4 T Cells Via Fas Ligand-Enhanced IFN-γ and Nitric Oxide.

TGF-β Influences the Life and Death Decisions of T Lymphocytes

Switching on of the proliferation or apoptosis of activated human T lymphocytes by IFN-gamma is correlated with the differential expression of the alpha- and beta-chains of its receptor.

Dissociation Of Cytokine Signals For Proliferation And Apoptosis

Combined loss of the BH3-only proteins Bim and Bmf restores B-cell development and function in TACI-Ig transgenic mice

TGF-β Promotes Stem-Like T Cells Via Enforcing Their Lymphoid Tissue Retention

Interferon gamma regulates a complex pro-survival signal network in chronic lymphocytic leukemia

T cell–derived interferon-γ programs stem cell death in immune-mediated intestinal damage

Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons

IFNα activates dormant haematopoietic stem cells in vivo

Transient inhibition of type I interferon enhances CD8+ T cell stemness and vaccine protection

Cognate CD4+ T Cells Enhance CTL Survival and Memory Programming Via IL-2, CD40L and Acquired Pmhc-I Signaling (46.16)

Th Cells Promote Ctl Survival and Memory Via Acquired Pmhc-I and Endogenous Il-2 and Cd40l Signaling and by Modulating Apoptosis-Controlling Pathways

TGF-β regulates the stem-like state of PD-1+ TCF-1+ virus-specific CD8 T cells during chronic infection

Developing and Activated T Cell Survival Depends on Differential Signaling Pathways to Regulate Anti-Apoptotic Bcl-x(L).

Cutting edge: IFN-γ enables APC to promote memory Th17 and Abate Th1 cell development

Recombinant IFN-alpha (2b) increases the expression of apoptosis receptor CD95 and chemokine receptors CCR1 and CCR3 in monocytoid cells

Efficient T Cell Activation Via a Toll-Interleukin 1 Receptor-independent Pathway.

Steady-state, therapeutic, and helminth-induced IL-4 compromise protective CD8 T cell bystander activation

Cancer cells resistant to immune checkpoint blockade acquire interferon-associated epigenetic memory to sustain T cell dysfunction